文献速递糖尿病

基于单基因糖尿病基因常见变异构建的多基因风险评分与年轻起病2型糖尿病及心血管-肾脏并发症相关

A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular-kidney complications.
PubMed 文献 · Diabetologia · 2024-11-23

研究基于全外显子组测序,利用34个单基因糖尿病基因的135个常见变异构建加权多基因风险评分(wPRS)。在发现队列(453例年轻起病2型糖尿病[YOD]和405例非YOD)中变异OR为1.00至2.61;验证队列(920例YOD和4910例非YOD)中,wPRS最高10%组较最低10%组YOD的OR为1.42(95%CI 1.03,1.95,p=0.033)。在2313例2型糖尿病患者中,标准化wPRS与心血管事件(HR 1.16)、肾脏事件(HR 1.09)及心血管-肾脏事件(HR 1.10)风险升高相关。

要点

  • 基于34个单基因糖尿病基因135个常见变异构建的wPRS与年轻起病2型糖尿病风险相关。
  • 验证队列中wPRS最高10%组较最低10%组YOD的OR为1.42(95%CI 1.03,1.95,p=0.033)。
  • 在2型糖尿病患者中,标准化wPRS与心血管-肾脏事件风险升高相关(HR 1.10,95%CI 1.03,1.16,p=0.003)。

核心结论

  • 单基因糖尿病基因的常见变异增加年轻起病2型糖尿病及心血管-肾脏事件风险。

研究设计与样本

  • 利用全外显子组测序数据,基于34个单基因糖尿病基因的135个常见变异(次要等位基因频率>0.01,连锁不平衡r2>0.2)构建加权多基因风险评分(wPRS)。
  • 发现队列为453例年轻起病2型糖尿病(YOD,40岁前诊断)成人(中位[IQR]年龄39.7[34.9-46.9]岁)和405例非YOD者(中位[IQR]年龄56.7[50.3-61.0]岁)。
  • 验证队列包括独立横断面队列(920例YOD和4910例非YOD,基于芯片基因分型)以及一个2型糖尿病前瞻性队列(2313例,中位[IQR]年龄53.4[45.4-61.7]岁,病程4.0[1.0-9.0]年,中位随访17.5[14.4-21.8]年)用于心血管和肾脏事件分析。

主要发现

  • 发现队列中,135个常见变异对YOD的OR范围为1.00至2.61。
  • 验证队列中,wPRS最高10%组较最低10%组YOD的OR为1.42(95%CI 1.03,1.95,p=0.033)。
  • 在2313例2型糖尿病患者中,标准化wPRS与心血管事件风险升高相关(HR 1.16,95%CI 1.06,1.27,p=0.001),与肾脏事件风险升高相关(HR 1.09,95%CI 1.02,1.16,p=0.013),与心血管-肾脏事件风险升高相关(HR 1.10,95%CI 1.03,1.16,p=0.003)。
  • 以「wPRS最低20%且基线病程<5年」组为参照,「wPRS最高20%且基线病程5至<10年」组心血管-肾脏事件的未调整HR为1.60(95%CI 1.17,2.19,p=0.003),调整后HR为1.62(95%CI 1.16,2.26,p=0.005);「wPRS最低20%且基线病程≥10年」组的未调整HR为1.38(95%CI 0.97,1.98,p=0.075),调整后HR为1.06(95%CI 0.72,1.57,p=0.752)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Monogenic diabetes is caused by rare mutations in genes usually implicated in beta cell biology. Common variants of monogenic diabetes genes (MDG) may jointly influence the risk of young-onset type 2 diabetes (YOD, diagnosed before the age of 40 years) and cardiovascular and kidney events. METHODS: Using whole-exome sequencing data, we constructed a weighted polygenic risk score (wPRS) consisting of 135 common variants (minor allele frequency >0.01) of 34 MDG based on r2>0.2 for linkage disequilibrium in a discovery case-control cohort of 453 adults with YOD (median [IQR] age 39.7 [34.9-46.9] years) and 405 without YOD (median [IQR] age 56.7 [50.3-61.0] years), followed by validation in an independent cross-sectional cohort with array-based genotyping for YOD and a prospective cohort of individuals with type 2 diabetes for cardiovascular and kidney events. RESULTS: In the discovery cohort, the OR of the 135 common variants for YOD ranged from 1.00 to 2.61. In the validation cohort (920 YOD and 4910 non-YOD), top-10%-wPRS was associated with an OR of 1.42 (95% CI 1.03, 1.95, p=0.033) for YOD compared with bottom-10%-wPRS. In 2313 individuals with type 2 diabetes (median [IQR]: age 53.4 [45.4-61.7] years; disease duration 4.0 [1.0-9.0] years) observed for a median (IQR) of 17.5 (14.4-21.8) years, standardised wPRS was associated with increased HR for incident cardiovascular events (1.16 [95% CI 1.06, 1.27], p=0.001), kidney events (1.09 [95% CI 1.02, 1.16], p=0.013) and cardiovascular-kidney events (1.10 [95% CI 1.03, 1.16], p=0.003). Using the 'bottom-20%-wPRS plus baseline disease duration <5 years' group as referent, the 'top-20%-wPRS plus baseline disease duration 5 to <10 years' group had unadjusted and adjusted HR of 1.60 (95% CI 1.17, 2.19, p=0.003) and 1.62 (95% CI 1.16, 2.26, p=0.005), respectively, for cardiovascular-kidney events compared with 1.38 (95% CI 0.97, 1.98, p=0.075) and 1.06 (95% CI 0.72, 1.57, p=0.752) in the 'bottom-20%-wPRS plus baseline disease duration ≥10 years' group. CONCLUSIONS/INTERPRETATION: Common variants of MDG increased risk for YOD and cardiovascular-kidney events.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. O CK, Fan B, Tsoi STF, et al. A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular-kidney complications. Diabetologia. 2024. PMID: 39579208. doi:10.1007/s00125-024-06320-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。